Medpace Holdings, Inc. Common Stock (MEDP)
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
- Headquarters
- United States
- Employees
- 6,500
- Market Cap
- $16.1B
About Medpace Holdings, Inc. Common Stock
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
SentiSense also tracks daily options readings for Medpace Holdings, Inc. Common Stock: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Medpace Holdings, Inc. Common Stock stock analysis, sentiment tracking, and market intelligence on SentiSense.